DAA2370 |
major histocompatibility complex, class II, DR beta 1 increases with age |
Molecular |
frontal lobe |
Human |
HLA-DRB1 |
84.8% Increase Gene Expression Level |
|
DAA2369 |
major histocompatibility complex, class II, DR alpha increases with age |
Molecular |
frontal lobe |
Human |
HLA-DRA |
135.3% Increase Gene Expression Level |
|
DAA2196 |
complement component 1, q subcomponent, C chain increases with age |
Molecular |
frontal lobe |
Human |
C1QC |
126.1% Increase Gene Expression Level |
|
DAA2350 |
major histocompatibility complex, class I-related increases with age |
Molecular |
frontal lobe |
Human |
MR1 |
32.2% Increase Gene Expression Level |
|
DAA2203 |
Clusterin increases with age |
Molecular |
frontal lobe |
Human |
CLU |
56.5% Increase Gene Expression Level |
|
DAA2162 |
Fc fragment of IgG, low affinity IIIb, receptor (CD16b) increases with age |
Molecular |
frontal lobe |
Human |
FCGR3B |
261.1% Increase Gene Expression Level |
|
DAA1072 |
CYFIP2 A to I mRNA editing decreases |
Molecular |
frontal lobe |
Human |
CYFIP2 |
Increase mRNA Editing |
|
DAA2165 |
MHC class I polypeptide-related sequence A increases with age |
Molecular |
frontal lobe |
Human |
MICA |
39.5% Increase Gene Expression Level |
|
DAA2245 |
Thioredoxin interacting protein increases with age |
Molecular |
frontal lobe |
Human |
TXNIP |
277.8% Increase Gene Expression Level |
|
DAA2197 |
complement component 1, s subcomponent increases with age |
Molecular |
frontal lobe |
Human |
C1S |
71.9% Increase Gene Expression Level |
|
DAA2194 |
complement component 1, q subcomponent, A chain increases with age |
Molecular |
frontal lobe |
Human |
C1QA |
98.4% Increase Gene Expression Level |
|
DAA2242 |
myeloid differentiation primary response gene (88) increases with age |
Molecular |
frontal lobe |
Human |
MYD88 |
58.7% Increase Gene Expression Level |
|
DAA1086 |
Rhomboid Domain Containing 1 |
Molecular |
frontal lobe |
Human |
RHBDD1 |
Increase DNA Methylation |
|
DAA2292 |
Fc fragment of IgG, low affinity IIa, receptor (CD32) increases with age |
Molecular |
frontal lobe |
Human |
FCGR2A |
104.3% Increase Gene Expression Level |
|
DAA2246 |
Thioredoxin interacting protein increases with age |
Molecular |
frontal lobe |
Human |
TXNIP |
250.2% Increase Gene Expression Level |
|
DAA2236 |
CD14 molecule increases with age |
Molecular |
frontal lobe |
Human |
CD14 |
134.9% Increase Gene Expression Level |
|
DAA2243 |
S100 calcium binding protein A8 increases with age |
Molecular |
frontal lobe |
Human |
S100A8 |
921.4% Increase Gene Expression Level |
|
DAA2379 |
major histocompatibility complex, class I, B increases with age |
Molecular |
frontal lobe |
Human |
HLA-B |
39.0% Increase Gene Expression Level |
|
DAA2371 |
major histocompatibility complex, class II, DR beta 4 increases with age |
Molecular |
frontal lobe |
Human |
HLA-DRB4 |
88.5% Increase Gene Expression Level |
|
DAA2144 |
Fc fragment of IgG, high affinity Ia, receptor (CD64) increases with age |
Molecular |
frontal lobe |
Human |
FCGR1A |
157.3% Increase Gene Expression Level |
|
DAA2349 |
major histocompatibility complex, class I-related increases with age |
Molecular |
frontal lobe |
Human |
MR1 |
22.4% Increase Gene Expression Level |
|
DAA2200 |
complement factor H increases with age |
Molecular |
frontal lobe |
Human |
CFH |
210.8% Increase Gene Expression Level |
|
DAA1090 |
ATP/GTP Binding Protein-like 5 |
Molecular |
frontal lobe |
Human |
AGBL5 |
Increase DNA Methylation |
|
DAA2235 |
toll interacting protein decreases with age |
Molecular |
frontal lobe |
Human |
TOLLIP |
36.3% Decrease Gene Expression Level |
|
DAA2234 |
toll interacting protein decreases with age |
Molecular |
frontal lobe |
Human |
TOLLIP |
57.8% Decrease Gene Expression Level |
|